norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Top Cited Papers
Open Access
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 67 (3) , 549-558
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver InjuryGastroenterology, 2012
- Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitisDigestive and Liver Disease, 2011
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #Hepatology, 2009
- Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2 −/− mice†‡§Hepatology, 2009
- Bile acids: Trying to understand their chemistry and biology with the hope of helping patients #Hepatology, 2009
- Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndromeAtherosclerosis, 2006
- 24-norUrsodeoxycholic Acid Is Superior to Ursodeoxycholic Acid in the Treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) Knockout MiceGastroenterology, 2006
- Novel biotransformation and physiological properties of norursodeoxycholic acid in humans†‡Hepatology, 2005
- Ursodiol for Primary Sclerosing CholangitisNew England Journal of Medicine, 1997
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990